HUMAN BIOSPECIMENS FOR RESEARCH
Human Disease State Biospecimens for Research
CGT Global supplies human disease state biospecimens for research programs investigating immune function, biomarkers, therapeutic response, disease biology, diagnostic development, and translational applications.
Researchers can source material from selected disease state donor populations across autoimmune and inflammatory conditions, oncology, infectious disease, and other specialty indications.
Depending on donor and inventory availability, sample types may include whole blood, PBMCs, mononuclear cells, plasma, serum, and other project-specific biospecimens.
Need a specific diagnosis, donor profile, sample type, collection volume, or study requirement? Our team can review current inventory and evaluate custom sourcing options.
DISEASE STATE DONOR MATERIAL
Explore Disease State Biospecimens by Research Area
Different research programs require different disease populations, donor criteria, and biospecimen types. CGT Global supports studies across multiple therapeutic and disease research areas.
Availability changes as donor material is collected, allocated, and added to inventory. Contact our team to confirm the most current options for your study.
Autoimmune Disease Biospecimens
- Systemic Lupus Erythematosus, SLE
- Rheumatoid Arthritis, RA
- Sjögren's Syndrome
- Hashimoto's Disease
- Additional inflammatory conditions may be available
Oncology Biospecimens
- Acute Myeloid Leukemia, AML
- Chronic Lymphocytic Leukemia, CLL
- Breast Cancer
- Multiple Myeloma
- Additional oncology profiles may be available
Infectious Disease Biospecimens
- HIV
- Hepatitis C Virus, HCV
- Lyme Disease
- Additional infectious disease populations may be available
Additional Disease State Material
- Thoracic Endometriosis
- Specialty donor profiles
- Custom inclusion and exclusion criteria
- Prospective collection opportunities
The examples above do not represent every donor profile that may be available. Disease state inventory changes over time, and prospective sourcing may be possible for selected projects.
MULTIPLE BIOSPECIMEN TYPES
Disease State Sample Types
The right biospecimen depends on the biological question being studied. Depending on the donor and current inventory, disease state material may be available in multiple formats.
Whole Blood
Minimally processed blood for cellular, molecular, biomarker, diagnostic, and assay development workflows.
PBMCs and MNCs
Mononuclear immune cell populations for immune profiling, functional assays, biomarker research, and cell-based studies.
Plasma
Cell-free blood fraction for research involving cytokines, proteins, antibodies, biomarkers, and circulating analytes.
Serum
Serum samples can support antibody, protein, biomarker, and serological research workflows.
AVAILABLE DISEASE STATE PRODUCTS
Browse Disease State Biospecimens
Explore currently available disease state biospecimens. Select a product below to review the disease state, sample type, product specifications, and additional research information.
Looking for a condition or donor profile that is not shown? Contact CGT Global to ask about current inventory and custom sourcing options.
CONTROL POPULATIONS
Pair Disease State Samples With Healthy Donor Controls
Many disease research programs require healthy donor material for comparison with samples from affected populations.
Depending on the study, healthy control material can help researchers evaluate disease-associated differences in immune function, biomarkers, cellular phenotypes, molecular signatures, and other biological variables.
CGT Global can help researchers evaluate healthy donor and disease state biospecimen options within the same project.
Healthy Controls May Support
- Disease vs healthy comparisons
- Baseline biomarker studies
- Assay development
- Immune profiling
- Therapeutic response research
- Validation studies
- Translational research
PROJECT-SPECIFIC SOURCING
Looking for a Specific Disease State or Donor Profile?
Not every research program can be supported by standard inventory. Some studies require highly specific disease states, demographic characteristics, collection formats, treatment histories, or inclusion and exclusion criteria.
CGT Global can evaluate custom sourcing projects when existing inventory does not match the study requirements.
Our team can help determine whether the project is best supported through available cryopreserved material, fresh collection, repeat donor access, or prospective donor recruitment.
Tell Us What Your Study Requires
- Disease or diagnosis
- Donor demographics
- Inclusion criteria
- Exclusion criteria
- Sample type
- Collection volume
- Fresh or cryopreserved material
- Testing requirements
- Processing requirements
- Study timeline
- Repeat collection needs
- Documentation requirements
DONOR SELECTION
Disease State Donor Criteria
Donor characteristics can substantially affect disease-state research. CGT Global can evaluate projects based on the characteristics most relevant to the biological question being studied.
Diagnosis
Select material based on the disease state or clinical population relevant to the study.
Demographics
Projects may be evaluated for donor characteristics such as age, sex, and other demographic requirements.
Medical History
Medical and disease history may be considered when those variables are important to the research.
Sample Requirements
Sample type, collection volume, format, and processing can be aligned with downstream workflows.
Testing Criteria
Additional testing or donor characterization may be evaluated depending on the project.
Repeat Collections
Recallable donors may support studies requiring longitudinal sampling or additional material over time.
Share the inclusion criteria, exclusion criteria, required sample type, sample quantity, and study timeline with our team so we can evaluate whether the project can be supported.
LONGITUDINAL RESEARCH
Repeat Collections From Recallable Donors
Disease-state research does not always end with a single sample. Some studies require additional material from the same donor or multiple collections across different time points.
When donor availability and eligibility allow, recallable donors may support longitudinal research, follow-up sampling, assay reproducibility, and projects requiring additional material from a previously selected donor.
Recallable Donors May Support
- Longitudinal studies
- Repeat collections
- Follow-up samples
- Multiple study time points
- Additional material from selected donors
- Assay reproducibility studies
MULTI-ANALYTE RESEARCH
Complementary Disease State Biospecimens
Some studies benefit from evaluating more than one biospecimen type from the same disease population.
Depending on the individual donor and current inventory, CGT Global may be able to support projects requiring combinations of whole blood, PBMCs, mononuclear cells, plasma, serum, or other available material.
Cellular Analysis
PBMCs, mononuclear cells, or whole blood can support immune and cellular research workflows.
Soluble Biomarkers
Plasma and serum can support research involving proteins, antibodies, cytokines, and other circulating analytes.
Combined Study Designs
Multiple biospecimen types can support studies evaluating both cellular and soluble biological signals.
If your study requires samples from the same donor, tell us before planning the study around matched material. Availability depends on donor history, previously collected material, and current inventory.
RESEARCH APPLICATIONS
Disease State Biospecimens for Research Applications
Disease state biospecimens can help researchers study biological differences between healthy and affected populations using donor material relevant to the condition being investigated.
Depending on the specimen type and study design, disease state samples can support cellular, molecular, biomarker, diagnostic, and therapeutic research workflows.
Biomarker Discovery
Evaluate disease-associated proteins, cytokines, antibodies, molecular signals, and other circulating biomarkers.
Immune Profiling
Investigate immune cell populations, activation states, phenotypes, and disease-associated immune responses.
Drug Discovery
Use primary human disease-state material to support therapeutic screening, response profiling, and preclinical research.
Assay Development
Develop and optimize research assays using donor material relevant to the intended disease population.
Diagnostic Research
Evaluate candidate biomarkers, molecular signatures, and assay performance in disease-relevant samples.
Translational Research
Bridge laboratory research with biologically relevant human donor populations across different disease states.
Functional Studies
Study cellular behavior, immune function, signaling pathways, and biological responses using primary material.
Disease Modeling
Compare biological characteristics across healthy and disease-state donor populations to better understand disease-associated differences.
Longitudinal Research
Recallable donors may support studies evaluating biological changes over time when repeat collection is feasible.
CHOOSING THE RIGHT MATERIAL
Which Disease State Biospecimen Does Your Study Need?
The right sample type depends on the biological question your study is designed to answer.
Cellular studies may require whole blood or PBMCs, while biomarker and serological studies may be better suited to plasma or serum.
Choose Whole Blood When You Need
- A minimally processed blood matrix
- Multiple blood cell populations
- Cellular and soluble components together
- Hematology or diagnostic workflows
- Starting material for downstream isolation
Choose PBMCs or MNCs When You Need
- Mononuclear immune cells
- Immune profiling
- Flow cytometry
- Functional immune assays
- Cell-based research workflows
Choose Plasma When You Need
- Circulating proteins
- Cytokines
- Antibodies
- Soluble biomarkers
- Other circulating analytes
Choose Serum When You Need
- Serological assays
- Antibody research
- Protein analysis
- Biomarker studies
- Clot-derived fluid samples
BIOSPECIMEN COMPARISON
Compare Disease State Sample Types
Each biospecimen type provides access to different biological components and is suited to different research applications.
| Sample Type | Biological Material | Common Research Uses | Best Fit |
|---|---|---|---|
| Whole Blood | Cellular components, platelets, and plasma | Assay development, diagnostics, hematology, molecular research, biomarkers, and cell isolation | Studies requiring a more complete blood matrix |
| PBMCs / MNCs | Mononuclear immune cell populations | Immune profiling, flow cytometry, functional assays, biomarker research, and therapeutic studies | Cell-focused immune research |
| Plasma | Cell-free liquid fraction from anticoagulated blood | Proteins, cytokines, antibodies, circulating biomarkers, and soluble analytes | Soluble biomarker research |
| Serum | Liquid fraction remaining after coagulation | Antibody studies, protein analysis, serology, and biomarker research | Serological and antibody-focused studies |
Tell us the disease state, assay type, biological target, required sample quantity, and downstream workflow. Our team can help evaluate appropriate material for the research question.
THE CGT GLOBAL DIFFERENCE
Why Researchers Source Disease State Biospecimens From CGT Global
Disease-state sourcing is rarely a one-size-fits-all process. Researchers may need a specific diagnosis, donor profile, specimen type, quantity, collection method, or longitudinal study design.
CGT Global works with researchers to evaluate both available material and more specialized sourcing approaches based on project needs.
Multiple Biospecimen Types
Depending on donor and inventory availability, projects may be supported with whole blood, PBMCs, mononuclear cells, plasma, serum, and other relevant material.
Healthy and Disease State Donors
Researchers can evaluate healthy donor and disease-state material within the same project when appropriate for the study design.
Custom Donor Criteria
Projects can be evaluated based on diagnosis, demographics, inclusion and exclusion criteria, sample requirements, and other study-specific characteristics.
Recallable Donors
Repeat collections may support longitudinal studies, follow-up sampling, and additional material requests when donor eligibility and availability allow.
Custom Sourcing Support
When existing inventory does not meet the study requirements, CGT Global can evaluate prospective sourcing and project-specific collection options.
Responsive Project Support
Our team works with researchers to understand the disease population, sample type, collection requirements, quantity, and timeline behind each request.
RELATED BIOSPECIMENS
Explore Related Human Biospecimens
Disease-state research may require different biospecimen types depending on the biological target, assay, and study design. Explore related CGT Global products and sourcing options below.
Human PBMCs for Research
Explore cryopreserved PBMCs for immune profiling, flow cytometry, biomarker studies, therapeutic development, and cell-based research.
Peripheral BloodHuman Whole Blood
Source whole blood for assay development, biomarker research, diagnostic workflows, molecular studies, and downstream cell isolation.
Large-Scale Starting MaterialHuman Leukopaks
Explore larger-scale leukapheresis material for immune cell isolation and downstream research applications.
Targeted Cell PopulationsIsolated Human Cells
Source selected immune cell populations for cell-specific assays, immunology, and therapeutic research workflows.
Bulk Cell IsolationCellsExpress
Explore bulk cell isolation options for research programs requiring larger quantities of selected primary human cells.
Custom SourcingRequest a Disease State Project
Tell us the condition, donor criteria, sample type, quantity, and study requirements needed for your research.
FREQUENTLY ASKED QUESTIONS
Frequently Asked Questions About Disease State Biospecimens
What are disease state biospecimens?
Disease state biospecimens are human biological samples collected from donors with a particular diagnosis or medical condition for use in research.
What disease states are available from CGT Global?
Disease-state material may be available across selected autoimmune and inflammatory conditions, oncology, infectious disease, and specialty donor populations. Availability changes as material is allocated and new samples become available.
What types of disease state samples are available?
Depending on donor and inventory availability, disease-state material may include whole blood, PBMCs, mononuclear cells, plasma, serum, and other project-specific biospecimens.
Can I request a specific diagnosis?
Yes. Researchers can submit requests based on a specific diagnosis or disease population. CGT Global can review existing inventory and evaluate prospective sourcing when suitable material is not currently available.
Can I request specific donor criteria?
Yes. Projects may be evaluated for criteria involving demographics, medical history, diagnosis, sample requirements, testing needs, inclusion criteria, exclusion criteria, and other study-specific characteristics.
Can I source healthy controls with disease state samples?
Healthy donor material may be available for comparative research involving disease-state samples. Availability and matching criteria depend on the study requirements and current donor access.
Can I obtain repeat samples from the same donor?
Repeat collections may be possible from recallable donors when donor eligibility, availability, collection timing, and project requirements allow.
Can I request matched PBMCs, plasma, or serum?
Matched or complementary samples may be available depending on the individual donor and existing inventory. Researchers requiring matched material should confirm availability before planning the study around it.
Can CGT Global source rare disease populations?
CGT Global can evaluate custom sourcing requests involving less common conditions or highly specific donor criteria. Feasibility depends on the disease population, collection requirements, donor access, and study timeline.
How do I request disease state biospecimen pricing?
Submit a quote request with the disease state, sample type, quantity, donor criteria, testing requirements, and study timeline. CGT Global can then review appropriate inventory and sourcing options.
FIND THE RIGHT DONOR MATERIAL
Source Disease State Biospecimens for Your Research
Whether you need disease-state PBMCs, whole blood, plasma, serum, healthy donor controls, repeat collections, or a highly specific donor population, CGT Global can help evaluate the right sourcing approach.
Tell us the condition, donor requirements, sample type, quantity, research application, and study timeline.
Request Disease State Availability and Pricing